Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Current Medicinal Chemistry|May 1, 2023
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase DeficiencySurya K De
Current Medicinal Chemistry|May 22, 2023
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)Surya K De
Current Medicinal Chemistry|February 21, 2023
Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal CandidiasisSurya K De
Anti-Cancer Agents in Medicinal Chemistry|March 24, 2023
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with MyelofibrosisSurya K De
Recent Patents on Anti-Cancer Drug Discovery|February 28, 2023
New 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2<i>H</i>)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other DiseasesSurya K De
Anti-Cancer Agents in Medicinal Chemistry|December 5, 2024
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast CancerSurya K De
Current Medicinal Chemistry|July 26, 2023
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other DiseasesSurya K De
Recent Patents on Anti-Cancer Drug Discovery|December 8, 2022
Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other DiseasesSurya K De
Current Medicinal Chemistry|June 1, 2023
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating DiseasesSurya K De
Anti-Cancer Agents in Medicinal Chemistry|November 29, 2022
Novel 1,4-Dihydropyrido[2,3-B]Pyrazine-2,3-Dione Derivatives for Treating Cancer and Other Disorders Associated with KRAS ActivitySurya K De
Pageof 6